| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance
|
Tietjen, Ian
|
|
|
236 |
C |
p.
|
article
|
| 2 |
Defining diabetic mouse as a highly susceptible preclinical model for monkeypox virus infection
|
Shang, Chao
|
|
|
236 |
C |
p.
|
article
|
| 3 |
DHODH inhibitors: What will it take to get them into the clinic as antivirals?
|
Luganini, Anna
|
|
|
236 |
C |
p.
|
article
|
| 4 |
Editorial Board
|
|
|
|
236 |
C |
p.
|
article
|
| 5 |
Effectiveness of nucleoside analogs against Wetland virus infection
|
Wang, Rui
|
|
|
236 |
C |
p.
|
article
|
| 6 |
Ensitrelvir treatment–emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial
|
Uehara, Takeki
|
|
|
236 |
C |
p.
|
article
|
| 7 |
Lipid-targeting antiviral strategies: Current state and future perspectives
|
Blázquez, Ana-Belén
|
|
|
236 |
C |
p.
|
article
|
| 8 |
M49L and other drug resistance mutations emerging in individuals after administration of ensitrelvir in Japanese clinical settings
|
Inoue, Akira
|
|
|
236 |
C |
p.
|
article
|
| 9 |
Recombinant Pichinde reporter virus as a safe and suitable surrogate for high-throughput antiviral screening against highly pathogenic arenaviruses
|
Sacramento, Carolina Q.
|
|
|
236 |
C |
p.
|
article
|
| 10 |
Research progress of vimentin in viral infections
|
Zheng, Jiawei
|
|
|
236 |
C |
p.
|
article
|
| 11 |
25R,26-hydroxycholesterol and an oxysterol synthetic analog inhibit Varicella zoster Virus replication
|
Civra, Andrea
|
|
|
236 |
C |
p.
|
article
|
Journal description